Internal Medicine · Dunnellon, FL
NPI
1508849068
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
20021 SW 111th Pl
Dunnellon, FL, 34432
Phone (352) 465-1199
Groups this clinician bills Medicare through
Medicare paid, 2024
$48K
1,144 services
Medicare patients, 2024
191
Average age 78
Drug cost, 2024
$870K
11,811 prescriptions
Company payments, 2025
$1,751
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sirisha Chalasani was code 99214 (office e&m - established), 246 times for 150 patients. In total Sirisha Chalasani billed 1,144 services in 43 codes, and Medicare paid $48K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-05-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 246 | 150 | $83.89 | $21K |
| 99213 Office E&M - Established | Office | 141 | 102 | $65.00 | $9,166 |
| 99211 Office E&M - Established | Office | 117 | 12 | $16.05 | $1,878 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 67 | 67 | $125.61 | $8,416 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 46 | 46 | $17.94 | $825 |
| G0008 Administration of influenza virus vaccine | Office | 41 | 40 | $31.66 | $1,298 |
| 90656 Vaccine Product | Office | 38 | 38 | $21.90 | $832 |
| 99441 Telephone Services | Office | 14 | 13 | $41.18 | $577 |
By year: 2022 $60K for 1,130 services; 2023 $58K for 1,495 services; 2024 $48K for 1,144 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sirisha Chalasani prescribed most often to Medicare patients was Atorvastatin Calcium, with 735 prescriptions and refills. In total Sirisha Chalasani wrote 11,811 Medicare prescriptions that cost $870K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 735 | 2,072 | 218 | $5,247 |
| Levothyroxine Sodium Generic | 502 | 1,412 | 146 | $3,773 |
| Amlodipine Besylate Generic | 464 | 1,295 | 150 | $1,483 |
| Losartan Potassium Generic | 452 | 1,195 | 129 | $3,168 |
| Rosuvastatin Calcium Generic | 406 | 1,168 | 136 | $3,396 |
| Gabapentin Generic | 393 | 969 | 139 | $4,153 |
| Omeprazole Generic | 322 | 845 | 92 | $2,153 |
| Lisinopril Generic | 316 | 929 | 98 | $1,343 |
| Pantoprazole Sodium Generic | 312 | 824 | 113 | $2,295 |
| Simvastatin Generic | 261 | 772 | 76 | $1,230 |
| Duloxetine Hcl Generic | 257 | 620 | 74 | $3,421 |
| Tamsulosin Hcl Generic | 215 | 541 | 57 | $1,856 |
| Carvedilol Generic | 210 | 584 | 64 | $1,275 |
| Citalopram Hbr Citalopram Hydrobromide | 203 | 525 | 66 | $646 |
| Metformin Hcl Generic | 175 | 498 | 59 | $873 |
Brand drugs: 1,314 claims; generic drugs: 10,397 claims; opioid claims: 281.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sirisha Chalasani $1,751 ($1,751 in general payments such as food, travel and fees) from 17 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $440.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 14 | $440 |
| Novo Nordisk Inc NVO | 14 | $399 |
| GlaxoSmithKline, LLC. GSK | 11 | $165 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $136 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 4 | $106 |
| Abbvie Inc. ABBV | 4 | $85.42 |
| Astellas Pharma US Inc 4503.T | 4 | $80.42 |
| Lilly USA, LLC LLY | 4 | $73.21 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $68.01 |
| Amgen Inc. AMGN | 3 | $54.37 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.